ArticleFrontiers in oncology2026
Perioperative anesthetic management for resection of giant retroperitoneal tumors.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study was to summarize perioperative anesthetic management in patients undergoing resection of giant retroperitoneal tumors and to provide a reference for clinical practice. Methods: This retrospective study analyzed data from 10 patients who underwent elective resection of giant retroperitoneal tumors (maximum diameter ≥ 15 cm) at a single institution between January 2018 and December 2023. Demographic characteristics, tumor features, preoperative preparations, intraoperative hemodynamic data, fluid and blood product administration, and postoperative complications were collected and analyzed. Descriptive statistical methods were applied. Results: The cohort included 1 male and 9 female patients, with median mean age of 56.5 year-old (range, 24-79 year-old). The median maximum tumor diameter was 33 cm (range, 22-50 cm). Preoperative multidisciplinary team consultations were conducted in 8 patients, and interventional vascular embolization was performed in 7 patients. All patients received general anesthesia with endotracheal intubation. Invasive arterial pressure monitoring was used in all patients, central venous pressure monitoring in 9, and FloTrac™/Vigileo monitoring in 6. The median operative duration was 260 minutes. The median intraoperative blood loss was 2,700 mL, and the median cumulative duration of hypotension was 32 minutes. Eight patients received blood transfusions (The median cumulative transfusion volume of red blood cells and plasma was 2,650 mL). Vasoactive agents were administered in all patients. Postoperative complications included nausea and vomiting (3 cases), atelectasis (2 cases), pleural effusion (2 cases), and surgical site infection (2 cases). No perioperative mortality occurred. Conclusion: The principal anesthetic challenges during resection of giant retroperitoneal tumors were hemodynamic instability and massive hemorrhage. Comprehensive preoperative preparation, advanced hemodynamic monitoring, proactive management of intravascular volume, and adequate availability of blood products may be critical components in improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.